Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
―Going beyond the pill – Can technology enhancethe role of pharmaceutical products in the treatmentof chronic diseases‖
The opportunity and the challengeA growing demand for healthcarePeople are living longer.Patient populations are growing i...
A growing body of evidence onadherence!   “Increasing the effectiveness of   adherence interventions may   have a far grea...
An example of unmet need     Management of diabetic patients is approx 15% of national healthcare budget     80% of this b...
Are We Moving To A NewParadigm In Healthcare?
How far have we moved already?                                                       Use of data to                       ...
Who Will Intelligent Pharma Benefit?                Intelligent Pharmaceuticals will help patients to take  Patients      ...
―...achieving effective blood pressurecontrol would be approximatelyequivalent to eliminating alldeaths from accidents, or...
AstraZeneca - Digital Technology in Pharma
Upcoming SlideShare
Loading in …5
×

AstraZeneca - Digital Technology in Pharma

  • Be the first to comment

AstraZeneca - Digital Technology in Pharma

  1. 1. ―Going beyond the pill – Can technology enhancethe role of pharmaceutical products in the treatmentof chronic diseases‖
  2. 2. The opportunity and the challengeA growing demand for healthcarePeople are living longer.Patient populations are growing in emerging markets.Many diseases are still not well managed.Can increased use of technology aid in delivering healthcare topopulations?2
  3. 3. A growing body of evidence onadherence! “Increasing the effectiveness of adherence interventions may have a far greater impact on the health of the population than any improvement in specific medical treatments” WHO Report, 2003 “20% of initial scripts are never filled, and 40% to 70% of those patients who fill a script drop off therapy after four months” AZ Funded Market Research, 2005
  4. 4. An example of unmet need Management of diabetic patients is approx 15% of national healthcare budget 80% of this budget is spent on the downstream consequences of poor control
  5. 5. Are We Moving To A NewParadigm In Healthcare?
  6. 6. How far have we moved already? Use of data to tailor Sophisticated interventions to medication maximise the reminder, additi benefit of a onal disease treatment on Patient management, h overall health information ealthcare outcomes services and services and medication outcome reminder reporting Access to patient information
  7. 7. Who Will Intelligent Pharma Benefit? Intelligent Pharmaceuticals will help patients to take Patients control of their illnesses and wellness. The additional data provided by IntelligentHealthcare Pharmaceuticals will help physicians to monitor theirpractitioners patients and adjust treatment as appropriate Improved adherence and increased data will help Caregivers caregivers to look after the patient Payers Increased adherence will decrease costs for payers
  8. 8. ―...achieving effective blood pressurecontrol would be approximatelyequivalent to eliminating alldeaths from accidents, or frominfluenza and pneumonia combined.‖—David Cutler, Harvard University

    Be the first to comment

    Login to see the comments

  • NianLIU6

    Nov. 22, 2015

Views

Total views

2,137

On Slideshare

0

From embeds

0

Number of embeds

111

Actions

Downloads

85

Shares

0

Comments

0

Likes

1

×